Good MorningThe S&P 500 struggled for direction on Tuesday despite the passage of a new stimulus bill by Congress. The bill is worth $900 billion and already facing stiff criticism due to the amount of pork and frivolous spending it includes. The average American is slated to receive just $600 of the money with many expected to receive their checks within weeks. The S&P 500 traded in a very tight range and closed with nearly no movement versus the prior session.
On the economic front, the number of existing homes sold in the month of November fell less than expected versus the previous month. The number of homes sold comes out to 6.69 million on an annualized basis and is up more than 25% on a year-over-year basis. Looking forward, the sale of homes is not expected to slacken in 2020 and will drive gains in related sectors like home improvement as well.
Featured: 5 Best Stocks Under $5 to Buy Now (Ad) 
|
Tech | | | In the middle of last year, Tesla's losses were piling up, sales weren't enough to cover expenses and big debt payments loomed. The situation was so bad that one influential Wall Street analyst raised the possibility that Tesla wouldn't be able to pay its bills and would have to be restructured fina... Read the Full Story |
|
From Our Partners2025 is off to a turbulent start—markets are swinging wildly, inflation pressures remain high, and recession fears are creeping back into headlines.
But even in uncertain times, innovation doesn’t slow down.
In fact, artificial intelligence (AI) is accelerating faster than ever—creating new profit opportunities while the broader market struggles.
Our latest research reveals two AI stocks trading under $15 that could thrive even as volatility grows. These under-the-radar companies are positioned to ride the next wave of AI-driven demand—and they’re still flying below most investors’ radar. | | | 👉[Click here to access your FREE AI stocks report now.] |
|
Markets | | | Asian shares have declined, extending losses on growing worries over a new, potentially more infectious strain of the coronavirus that has countries around the world restricting travel from the United Kingdom Read the Full Story |
|
Markets | | | Shares retreated in Asia on Tuesday after the U.S. included dozens more Chinese companies in a Commerce Department blacklist in another blow to markets already wracked with uncertainty over the pandemic.
The Shanghai Composite index dropped nearly 2% on Tuesday and other regional mar... Read the Full Story |
|
From Our PartnersAs you may have seen over the last few weeks, I've been giving out special daily setups on my favorite ticker.
We’ve been taking these setups @ 10AM and so far, we've posted 28 different payouts …
Each of which were delivered at exactly 4PM as the market closed.
You see, these setups require zero oversight and have shown the power to deliver in the most chaotic market conditions.
And after a few weeks of fine-tuning … I knew it was time to let you in on The 4 PM Payout Plan.
That's why Jack Carter and I pulled back the curtain to reveal how we've been able to nail in a 96% win rate in the same window the market lost 11 trillion dollars in value. | | | We also revealed how you can find and execute these setups on your own without any help at all. |
|
Politics | | | European shares and U.S. futures advanced Tuesday after American lawmakers approved a $900 billion package of measures to help the economy get through the pandemic.
Stocks rose in Paris, London and Frankfurt but fell in Tokyo and other Asian markets. The Shanghai Composite index drop... Read the Full Story |
|
Healthcare | | | The massive, year-end catchall bill that Congress has passed combines $900 billion in COVID-19 aid with a $1.4 trillion spending bill and reams of other unfinished legislation on taxes, energy, education and health care Read the Full Story |
|
From Our PartnersJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%...
Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." | | | Click here to watch the demo… |
|
Stocks | | | Special purpose acquisition company (SPAC) RMG Acquisition (NYSE: RMG) will reverse merge with Romeo Power Technology, a battery technology company accommodating the electric vehicle (EV) market. Shares have seen a boost due to the EV and SPAC mania boosted by the likes of QuantumScape Corporation (... Read the Full Story |
|
Markets | | |
For the risk-averse investor, the last several months have been like a rocket sled clear through the center of Crazy Town. Stocks that seemed to have little in the way of visible support shot up to multiples of their previous valuations, while long-term holdings began to collapse. I won't even bri... Read the Full Story |
|
Markets | | | The RealReal, Inc (NASDAQ:REAL) is the operator of an online shopping portal for consignment and vendor-originated luxury items. Now, the luxury market was one of the worst-hit over the summer but the rebound is on Read the Full Story |
|
Markets | | | Spaceship manufacturer Virgin Galactic Holdings, Inc. (NYSE: SPCE) stock imploded on the failure of a test flight sending shares collapsing from a high of $35.82 to a low of $23.78 in eight trading sessions. Read the Full Story |
|
Markets | | | Leslie’s (NASDAQ:LESL) has been around for about 60 years but only went public two months ago. That is surprising because the company is uniquely positioned as the largest supplier of pool and spa supplies Read the Full Story |
|
The Early Bird Stock Of The Day CRISPR Therapeutics is a gene-editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene-editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom. For more information, please visit www.crisprtx.com. | | View Today's Stock Pick |
|
